SYDNEY, AUSTRALIA: Wesfarmers Limited has acquired 95.1 million shares in Australian Pharmaceutical Industries Limited (API) representing 19.3 per cent of API’s shares outstanding. The acquisition was made pursuant to the Undertaking Agreement entered into on 9 July 2021 with Washington H. Soul Pattinson and Company Limited (WHSP). Wesfarmers remains committed to pursuing its proposal to…